Serologicals Corporation to Present at JPMorgan Small Cap Conference
October 26 2005 - 9:00AM
Business Wire
Serologicals Corporation (NASDAQ: SERO) today announced that it is
scheduled to give an investor presentation at the JPMorgan Small
Cap Conference on November 2, 2005. Bud Ingalls, Vice President,
Finance and Chief Financial Officer for Serologicals Corporation,
will be making the presentation, scheduled for 8:00 a.m. (ET) at
The Four Seasons Hotel in Boston, MA. The presentation will be web
cast live (audio only) and can be accessed through the Company's
website at www.serologicals.com, or at
http://equityconferences.jpmorgan.com. Serologicals Corporation
(NASDAQ: SERO), headquartered in Atlanta, GA., is a global leader
in developing and commercializing consumable biological products,
enabling technologies and services in support of biological
research, drug discovery, and the bioprocessing of life-enhancing
products. Our customers include researchers at major life science
companies and leading research institutions involved in key
disciplines, such as neurology, oncology, hematology, immunology,
cardiology, proteomics, infectious diseases, cell signaling and
stem cell research. In addition, Serologicals is the world's
leading provider of monoclonal antibodies for the blood typing
industry. Serologicals employs a total of more than 1,000 people
worldwide in three Serologicals' companies: Chemicon International,
headquartered in Temecula, California, Upstate Group, LLC,
headquartered in Charlottesville, Virginia and Celliance
Corporation, headquartered in Atlanta Georgia. For more
information, please visit our website: www.serologicals.com.
Serologicals (NASDAQ:SERO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Serologicals (NASDAQ:SERO)
Historical Stock Chart
From Aug 2023 to Aug 2024